Huntington's disease trials in Switzerland

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease

  Where

  Gümligen

  Age

  21 years to 70 years

  People

  32 worldwide

  Run by

  Sarepta Therapeutics, Inc.

  See details and how to joinNCT07536061
• Phase 3Taking people
  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  Where

  Basel, Muri bei Bern

  Age

  21 years to 70 years

  People

  770 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07326709 · EU 2025-522227-99-00
• No phaseTaking people
  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  Where

  Gümligen, Zurich

  Age

  18 years and over

  People

  35,000 worldwide

  Run by

  CHDI Foundation, Inc.

  See details and how to joinNCT01574053